Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome.

Blood - 30 Aug 2012

Taga Takashi, Saito Akiko Moriya, Kudo Kazuko, Tomizawa Daisuke, Terui Kiminori, Moritake Hiroshi, Kinoshita Akitoshi, Iwamoto Shotaro, Nakayama Hideki, Takahashi Hiroyuki, Tawa Akio, Shimada Akira, Taki Tomohiko, Kigasawa Hisato, Koh Katsuyoshi, Adachi Souichi

Abstract excerpt

Myeloid leukemia in Down syndrome (ML-DS) is associated with good response to chemotherapy and favorable prognosis. Because little research has been focused on refractory/relapsed (R/R) cases, we conducted a retrospective analysis for R/R ML-DS. Among ML-DS patients diagnosed between 2000 and 201...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Down Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GATA1 Transcription Factor

Share to Karyotype

Share to Leukemia, Myeloid

Share to Multivariate Analysis

Share to Recurrence

Share to Transplantation, Homologous

Source

Identifiers

PMID: 22776818
DOI: 10.1182/blood-2012-03-414755

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22776818-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome.PMID 22776818Read ↗

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international studySemantic proximity Read ↗

Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.Semantic proximity Read ↗

Long-term outcome for Down syndrome patients with hematopoietic disorders.Semantic proximity Read ↗

Clinical and biological aspects of myeloid leukemia in Down syndrome.Semantic proximity Read ↗

Down syndrome and leukemia: An insight into the disease biology and current treatment options.Semantic proximity Read ↗

Acute leukemia in children with Down syndromeSemantic proximity Read ↗

Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.Semantic proximity Read ↗

Hematological disorders in children with Down syndrome.Semantic proximity Read ↗

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.Semantic proximity Read ↗

Advances in molecular characterization of myeloid proliferations associated with Down syndromeSemantic proximity Read ↗

Unique clinical and biological features of leukemia in Down syndrome children.Semantic proximity Read ↗

Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.